Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer

Molecular Nutrition and Food Research

Volumn 56, Issue 10, 2012, Pages 1520-1531

  Tang, Feng Yao ^a   Pai, Man Hui ^b   Kuo, Yueh Hsiung ^a   Wang, Xiang Dong ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TUFTS UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

catenin; Colon cancer; Fish oil; Lycopene; PCNA

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CAROTENOID; CDKN1A PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; CYCLOOXYGENASE 2; FISH OIL; GELATINASE B; LYCOPENE; MATRILYSIN; MMP9 PROTEIN, MOUSE; MYC PROTEIN; MYC PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL STRAIN HT29; COLON TUMOR; DISEASE COURSE; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ANTICARCINOGENIC AGENTS; BETA CATENIN; CAROTENOIDS; COLONIC NEOPLASMS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DRUG SYNERGISM; FISH OILS; HT29 CELLS; HUMANS; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC;

MUS;

EID: 84867047887     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200098     Document Type: Article

References (37)

1. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62, 10-29.
2. Samuels, Y., Wang, Z., Bardelli, A., Silliman, N. et al., High frequency of mutations of the PIK3CA gene in human cancers. Science 2004, 304, 554.
3. Walther, A., Johnstone, E., Swanton, C., Midgley, R. et al., Genetic prognostic and predictive markers in colorectal cancer. Nat. Rev. Cancer 2009, 9, 489-499.
4. Wang, Y. K., Zhu, Y. L., Qiu, F. M., Zhang, T. et al., Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133 +primary colon cancer cells. Carcinogenesis 2010, 31, 1376-1380.
5. Hanahan, D., Weinberg, R. A., The hallmarks of cancer. Cell 2000, 100, 57-70.
6. Hanahan, D., Weinberg, R. A., Hallmarks of cancer: the next generation. Cell 2011, 144, 646-674.
7. Kirimlioglu, H., Kirimlioglu, V., Yilmaz, S., Sagir, V. et al., Role of matrix metalloproteinase-7 in colorectal adenomas. Dig. Dis. Sci. 2006, 51, 2068-2072.
8. Lynch, C. C., Vargo-Gogola, T., Matrisian, L. M., Fingleton, B., Cleavage of E-cadherin by matrix metalloproteinase-7 promotes cellular proliferation in nontransformed cell lines via activation of RhoA. J. Oncol. 2010, 530745.
9. Oshima, T., Akaike, M., Yoshihara, K., Shiozawa, M. et al., Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer. Oncol. Rep. 2008, 20, 359-364.
10. Koskensalo, S., Louhimo, J., Nordling, S., Hagstrom, J. et al., MMP-7 as a prognostic marker in colorectal cancer. Tumour. Biol. 2011, 32, 259-264.
11. Fang, Y. J., Lu, Z. H., Wang, G. Q., Pan, Z. Z. et al., Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int. J. Colorectal Dis. 2009, 24, 875-884.
12. Brabletz, T., Jung, A., Dag, S., Hlubek, F. et al., Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 1999, 155, 1033-1038.
13. Benbow, U., Brinckerhoff, C. E., The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 1997, 15, 519-526.
14. Crawford, H. C., Fingleton, B. M., Rudolph-Owen, L. A., Goss, K. J. et al., The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999, 18, 2883-2891.
15. Peifer, M., Beta-catenin as oncogene: the smoking gun. Science 1997, 275, 1752-1753.
16. Liu, C., Russell, R. M., Wang, X. D., Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J. Nutr. 2006, 136, 106-111.
17. Liu, C., Lian, F., Smith, D. E., Russell, R. M. et al., Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res. 2003, 63, 3138-3144.
18. Tang, L., Jin, T., Zeng, X., Wang, J. S., Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J. Nutr. 2005, 135, 287-290.
19. Tang, F. Y., Pai, M. H., Wang, X. D., Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model. J. Agric. Food Chem. 2011, 59, 9011-9021.
20. Franceschi, S., Bidoli, E., La, V. C., Talamini, R. et al., Tomatoes and risk of digestive-tract cancers. Int. J. Cancer 1994, 59, 181-184.
21. Erhardt, J. G., Meisner, C., Bode, J. C., Bode, C., Lycopene, beta-carotene, and colorectal adenomas. Am. J. Clin. Nutr. 2003, 78, 1219-1224.
22. Murtaugh, M. A., Ma, K. N., Benson, J., Curtin, K. et al., Antioxidants, carotenoids, and risk of rectal cancer. Am. J. Epidemiol. 2004, 159, 32-41.
23. Sengupta, A., Ghosh, S., Das, S., Tomato and garlic can modulate azoxymethane-induced colon carcinogenesis in rats. Eur. J. Cancer Prev. 2003, 12, 195-200.
24. Guttenplan, J. B., Chen, M., Kosinska, W., Thompson, S. et al., Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett. 2001, 164, 1-6.
25. Begin, M. E., Ells, G., Das, U. N., Horrobin, D. F., Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J. Natl. Cancer Inst. 1986, 77, 1053-1062.
26. Reddy, B. S., Burill, C., Rigotty, J., Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res. 1991, 51, 487-491.
27. Cave, W. T., Jr., Dietary omega-3 polyunsaturated fats and breast cancer. Nutrition 1996, 12, S39-S42.
28. Cave, W. T., Jr., Dietary n-3 (omega-3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J. 1991, 5, 2160-2166.
29. Huang, C. S., Liao, J. W., Hu, M. L., Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J. Nutr. 2008, 138, 538-543.
30. Lin, M. C., Wang, F. Y., Kuo, Y. H., Tang, F. Y., Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells. J. Agric. Food Chem. 2011, 59, 11304-11318.
31. Tang, F. Y., Shih, C. J., Cheng, L. H., Ho, H. J. et al., Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Mol. Nutr. Food Res. 2008, 52, 646-654.
32. Tang, F. Y., Cho, H. J., Pai, M. H., Chen, Y. H., Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J. Nutr. Biochem. 2009, 20, 426-434.
33. Tang, F. Y., Cho, H. J., Pai, M. H., Chen, Y. H., Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J. Nutr. Biochem. 2009, 20, 426-434.
34. Nagata, C., Takatsuka, N., Shimizu, H., Soy and fish oil intake and mortality in a Japanese community. Am. J. Epidemiol. 2002, 156, 824-831.
35. Reagan-Shaw, S., Nihal, M., Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659-661.
36. O'Neill, M. E., Carroll, Y., Corridan, B., Olmedilla, B. et al., A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Brit. J. Nutr. 2001, 85, 499-507.
37. Calviello, G., Di, N. F., Gragnoli, S., Piccioni, E. et al., n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 2004, 25, 2303-2310.